HL-A antibody response in patients with acute myelogenous leukaemia treated by immunotherapy.
D000917:Antibody Formation; D000951:Antigens, Neoplasm; D001500:BCG Vaccine; D001793:Blood Preservation; D003037:Cobalt Radioisotopes; D003601:Cytotoxicity Tests, Immunologic; D006801:Humans; D007167:Immunotherapy; D007518:Isoantibodies; D015470:Leukemia, Myeloid, Acute / Q000276:immunology* / Q000628:therapy; D017710:Lymphocyte Transfusion; D008214:Lymphocytes / Q000528:radiation effects; D009163:Mycobacterium bovis / Q000276:immunology; D011830:Radiation Effects; D012075:Remission, Spontaneous
D000951:Antigens, Neoplasm; D001500:BCG Vaccine; D003037:Cobalt Radioisotopes; D007518:Isoantibodies